oesteoarthritis
Allegro confirms successful safety testing of osteoarthritis treatment
April 17, 2025Research and Development Allegro, Osteoporosis, joint disease, oesteoarthritis, pretrial
Allegro’s hydrocelin treatment for osteoarthritis has demonstrated a satisfactory safety profile, giving it potential to become a leading disease-modifying treatment …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
Highlighting the value of lab research for healthcare innovation
November 2, 2026
